Molecular classification of multiple myeloma (MM) based on gene expression profiling (GEP) and fluorescence in situ hybridisation (FISH) is an independent predictor for event free survival (EFS).

被引：0
|
作者：
Hose, D
Rossi, JF
Ittrich, C
De Vos, J
Rème, T
Benner, A
Mahtouk, KN
del Val, C
Moreaux, J
Hotz-Wagenblatt, A
Jonnakut, S
Raab, M
Kaukel, P
Moos, M
Grau, V
Jauch, A
Jourdan, E
Cremer, FW
Klein, B
Goldschmidt, H
机构：
[1] Univ Klinikum Heidelberg, Med Klin & Poliklin 5, Heidelberg, Germany
[2] CHU Montpellier, Montpellier, France
[3] INSERM, U475, Montpellier, France
[4] DKFZ, Abt Biostat, Heidelberg, Germany
[5] Univ Klinikum Heidelberg, Inst Humangenet, Heidelberg, Germany
[6] CellGen SA, Montpellier, France
[7] DKFZ, Abt Mol Biophys, Heidelberg, Germany
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
507
引用
收藏
页码：151A / 152A
页数：2
相关论文
共 5 条
  • [1] A molecular classification of multiple myeloma (MM) based on gene expression profiling and fluorescence in situ hybridisation as independent prognostic factor for event free survival (EFS)
    Hose, Dirk
    De Vos, John
    Ittrich, Carina
    Rossi, Jean-Francois
    Reme, Thierry
    Benner, Axel
    Mahtouk, Karene
    del Val, Coral
    Hotz-Wagenblatt, Agnes
    Moreaux, Jerome
    Jonnakut, Sunitha
    Raab, Marc
    Kaukel, Philine
    Moos, Marion
    Grau, Veronique
    Jauch, Anna
    Jourdan, Eric
    Cremer, Friedrich W.
    Klein, Bernard
    Goldschmidt, Hartmut
    EJC SUPPLEMENTS, 2006, 4 (06): : 34 - 35
  • [2] A new molecular classification of multiple myeloma using gene expression profiling and fluorescence in situ hybridisation as predictor for event free survival.
    Hose, D
    Rossi, JF
    Ittrich, C
    DeVos, J
    Benner, A
    Reme, T
    Bila, J
    Grau, V
    Raab, M
    Kaukel, P
    Jourdan, E
    Moos, M
    Theil, AC
    Jauch, A
    Goldschmidt, H
    Klein, B
    Cremer, FW
    BLOOD, 2004, 104 (11) : 25A - 25A
  • [3] Clonal and subclonal cytogenetic aberrations:: Association with D-type cyclin expression and event-free survival (EFS) in multiple myeloma (MM).
    Hose, Dirk
    DeVos, John
    Mueller, Nadine
    Rossi, Jean-Francois
    Heib, Christiane
    Mahtouk, Karene
    Hundemer, Michael
    Reme, Thierry X.
    Benner, Axel
    Moreaux, Jerome
    Pantesco, Veronique
    Moehler, Thomas
    Jourdan, Eric
    Jauch, Anna
    Klein, Bernard
    Goldschmidt, Hartmut
    BLOOD, 2006, 108 (11) : 982A - 982A
  • [4] Gene expression profiling (GEP)-defined risk and molecular subgroups assessed at baseline and at relapse: Collective impact on post-relapse survival of multiple myeloma (MM) treated with total therapies 2 and 3
    Nair, B.
    Shaughnessy, J.
    Alsayed, Y.
    Haessler, J.
    van Rhee, F.
    Hollmig, K.
    Pineda-Roman, M.
    Crowley, J.
    Barlogie, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [5] Gene Expression Profiling (GEP) of Whole Bone Marrow Biopsies in Complete Remission (BMB-CR) of Multiple Myeloma (MM) Patients Treated On Total Therapy Protocols - Normalization of GEP Signature in Comparison with Normal Donor BMB (BMB-NL) and Consequences for Progression-Free Survival (PFS)
    Heuck, Christoph
    Qu, Pingping
    Waheed, Sarah
    Usmani, Saad Z.
    van Rhee, Frits
    Dhodapkar, Madhav V.
    Epstein, Joshua
    Zhang, Qing
    Johann, Donald
    Barlogie, Bart
    BLOOD, 2012, 120 (21)
1